Inflammation research is one of the three major foci of the Medical Faculty of the Christian-Albrechts-University Kiel (CAU).
The Institute of Clinical Molecular Biology (ICMB) at the University Kiel is a recognized leader in translational genomic research in inflammatory barrier diseases. Main interests are in the complex interactions between human barrier organs and the environment in health and disease. This includes the generation of genetic risk maps and biomarker detection using cohort-based approaches as well as research on epigenetic/transcriptomal alterations and their validation in cell biological experiments in vitro, in standardized mouse models in vivo. Ultimately, we aim to translate the findings into the human diagnostic or therapeutic experiment.
The institute operates the largest university based next generation sequencing centre in Germany, commands a high throughput genotyping facility and is partner in the popgen biobank program with more than 80.000 patients in Schleswig-Holstein under long-term follow up.
Olshausenstrasse 40, KIEL 24118, Germany